Totaligent
TGNT · OTC
About TGNT
- Employees
- 0
- Headquarters
- Boca Raton, Florida
- Listed
- Jan 14, 2008
- Sector
- Communication Services
- Industry
- Media
- Website
- totaligent.com
TGNT key statistics
- Market cap
- 2.48M
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 28.76K
- Volume
- 10.05K
- Open price
- $0.0065
- High today
- $0.0065
- Low today
- $0.0065
- 52 Week high
- $0.056
- 52 Week low
- $0.0035
Totaligent (TGNT) at a glance
Totaligent (TGNT) last traded at $0.0065, with a market cap of 2.48M.
Volume so far is 10.05K shares, below the average of 28.76K shares a day.
Over the past year Totaligent has ranged from $0.0035 to $0.056, and now sits 6% of the way up that range.
TGNT news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
FDA's AI Push Ignites a new Biotech Arms Race and Totaligent may be quietly Positioning Itself at the Center
Similar companies
Companies in the same industry as Totaligent
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.